Work

AML-055 Outcomes Based on Sequential Use of Venetoclax Based Therapy and Targeted Therapy in Acute Myeloid Leukemia (AML)

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)01214-9

Authors: Maximilian Stahl, Rory M. Shallis, Andriy Derkach, Aaron D. Goldberg, Anthony Stein, Eytan M. Stein, Guido Marcucci, Amer M. Zeidan, Shai Shimony, Daniel J. DeAngelo, Richard M. Stone, Ibrahim Aldoss, Brian J. Ball, Jan Phillip Bewersdorf

Institutions: Dana-Farber Cancer Institute, Yale University, Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, City of Hope

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296532109

Cites:

Cited by:

Related to: 10